Physician
Internal Medicine
Dr. David W. Dempster, MD
|
|
Give Review
David Dempster practices Internal Medicine. He went to University of Washington School of Medicine. He received 1 awards: "Meaningful Use Stage 1 Certification". David Dempster is a published doctor and has 99 publications published. The lastest was: 'Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis.' He accepts Medicare.
Publications
- A Longitudinal Study of Skeletal Histomorphometry at 6 and 24 Months Across Four Bone Envelopes in Postmenopausal Women with Osteoporosis Receiving Teriparatide or Zol...
- Differential Effects of Teriparatide and Denosumab on Intact PTH and Bone Formation Indices: AVA Osteoporosis Study.
- Effect of Teriparatide on Bone Formation in the Human Femoral Neck.
- Bone histomorphometry in diabetes mellitus.
- Bone Density After Teriparatide Discontinuation in Premenopausal Idiopathic Osteoporosis.
- Erratum to: Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacat...
- Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture ...
- Autophagy in osteoblasts is involved in mineralization and bone homeostasis.
- Current Issues in the Presentation of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Fourth International Workshop.
- Effects of up to 5 Years of Denosumab Treatment on Bone Histology and Histomorphometry: The FREEDOM Study Extension.
- Teriparatide increases strength of the peripheral skeleton in premenopausal women with idiopathic osteoporosis: A pilot HR-pQCT study.
- Increased IL-6 Expression in Osteoclasts is Necessary but not Sufficient for the Development of Paget's Disease of Bone.
- Atypical subtrochanteric and diaphyseal femoral fractures: Second report of a task force of the American society for bone and mineral research.
- Teriparatide for Idiopathic Osteoporosis in Premenopausal Women: A Pilot Study.
- Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: a transiliac bone biopsy study.
- Role of ATF7-TAF12 interactions in the VDR hyper-sensitivity of osteoclast precursors in Paget's disease.
- Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee.
- Parathyroid hormone treatment improves the cortical bone micro-structure by improving the distribution of type I collagen in postmenopausal women with osteoporosis.
- Bone remodeling in postmenopausal women who discontinued denosumab treatment: Off-treatment biopsy study.
- PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism.
- Abnormal Bone Microarchitecture and Evidence of Osteoblast Dysfunction in Premenopausal Women with Idiopathic Osteoporosis.
- Osteoporosis and the burden of osteoporosis-related fractures.
- Vitamin D deficiency influences histomorphometric features of bone in primary hyperparathyroidism.
- Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62(P392L) mutation to Paget's disease.
- Skeletal microstructural abnormalities in postmenopausal women with chronic obstructive pulmonary disease.
- Three dimensional cancellous bone structure in hypoparathyroidism.
- Assessing fracture risk and effects of osteoporosis drugs: bone mineral density and beyond.
- TNFalpha receptor knockout in mice reduces adverse effects of magnesium deficiency on bone.
- PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation.
- Dynamic and structural properties of the skeleton in hypoparathyroidism.
- Bone quality determined by Fourier transform infrared imaging analysis in mild primary hyperparathyroidism.
- The effects of combination of alendronate and human parathyroid hormone(1-34) on bone strength are synergistic in the lumbar vertebra and additive in the femur of C57B...
- New observations on bone quality in mild primary hyperparathyroidism as determined by quantitative backscattered electron imaging.
- Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium.
- Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity.
- Recovery from skeletal fluorosis (an enigmatic, American case).
- Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease.
- Experimental models of Paget's disease.
- A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions o...
- Expression of measles virus nucleocapsid protein in osteoclasts induces Paget's disease-like bone lesions in mice.
- Effects of cyclic versus daily hPTH(1-34) regimens on bone strength in association with BMD, biochemical markers, and bone structure in mice.
- Ibandronate: the evolution of a once-a-month oral therapy for postmenopausal osteoporosis.
- Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.
- Normal human osteoclasts formed from peripheral blood monocytes express PTH type 1 receptors and are stimulated by PTH in the absence of osteoblasts.
- Therapeutic potential of curcumin in prostate cancer--V: Interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells.
- Trabecular bone response to mechanical and parathyroid hormone stimulation: the role of mechanical microenvironment.
- The pathophysiology of bone loss.
- Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study befor...
- Precision, accuracy, and reproducibility of dual X-ray absorptiometry measurements in mice in vivo.
- Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.
- Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research.
- Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research.
- Low bone formation in premenopausal women with idiopathic osteoporosis.
- Association of the dysbindin gene with bipolar affective disorder.
- Vitamin D economy in blacks.
- Increased resorptive activity and accompanying morphological alterations in osteoclasts derived from the oim/oim mouse model of osteogenesis imperfecta.
- Novel mutations in 5-HT3A and 5-HT3B receptor genes not associated with clozapine response.
- Hereditary hyperphosphatasia: 20 year follow-up and response to disodium etidronate.
- Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis.
- Insulin-like growth factor-I in men with idiopathic osteoporosis.
- Progress in geriatric care.
- [Effects of 1 alpha(OH)D3 on trabecular and cortical bone in ovariectomized rats].
- Issues in modern bone histomorphometry.
- Effects of denosumab on bone histomorphometry: the FREEDOM and STAND studies.
- Bone histomorphometry: a concise review for endocrinologists and clinicians.
- A SQSTM1/p62 mutation linked to Paget''s disease increases the osteoclastogenic potential of the bone microenvironment.
- Bisphosphonate associated osteonecrosis of the jaw.
- Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.
- Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.
- Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research.
- Bone microarchitecture and strength.
- Exploiting and bypassing the bone remodeling cycle to optimize the treatment of osteoporosis.
- Short-term immobilization-induced cancellous bone loss is limited to regions undergoing high turnover and/or modeling in mature rats.
- Resistance to bone resorbing effects of PTH in black women.
- Histomorphometric assessment of bone mass, structure, and remodeling: a comparison between healthy black and white premenopausal women.
- Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.
- The systemic effect of intraarticular administration of corticosteroid on markers of bone formation and bone resorption in patients with rheumatoid arthritis.
- Osteoclast demise in the rat: physiological versus degenerative cell death.
- Selective toxic effects of tamoxifen on osteoclasts: comparison with the effects of oestrogen.
- Effect of diacylglycerols on osteoclastic bone resorption.
- Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol.
- Relationships between bone structure in the iliac crest and bone structure and strength in the lumbar spine.
- Stimulation of bone resorption and osteoclast clear zone formation by low pH: a time-course study.
- Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis.
- Anabolic actions of parathyroid hormone on bone.
- Zinc is a potent inhibitor of osteoclastic bone resorption in vitro.
- Temporal changes in cancellous bone structure of rats immediately after ovariectomy.
- Short-term changes in histomorphometric and biochemical turnover markers and bone mineral density in estrogen-and/or dietary calcium-deficient rats.
- Lack of significant effect of carboxyl-terminal parathyroid hormone-related peptide fragments on isolated rat and chick osteoclasts.
- Effects of reciprocal treatment with estrogen and estrogen plus parathyroid hormone on bone structure and strength in ovariectomized rats.
- Effects of heparin on osteoclast activity.
- Relationships between quantitative histological measurements and noninvasive assessments of bone mass.
- Effects of combined and separate intermittent administration of low-dose human parathyroid hormone fragment (1-34) and 17 beta-estradiol on bone histomorphometry in ov...
- Effects of phorbol myristate acetate on rat and chick osteoclasts.
- Maintenance of cancellous bone connectivity in primary hyperparathyroidism: trabecular strut analysis.
- Lack of changes in histomorphometric, bone mass, and biochemical parameters in ovariohysterectomized dogs.
- Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study.
- Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
Schools
University Of Washington School Of Medicine
Doctors Specialties
- Internal Medicine
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
Education
-
Lenox Hill Hospital -
Virginia Mason Medical Center -
University of Washington School of Medicine
Drug Facts
| NPI NUMBER | 1861438558 | |
| NPPES Provider LastName | DEMPSTER | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 984054265 | |
| NPPES Provider State | WA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 189.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1861438558 |
| Last Name Of The Provider | DEMPSTER |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
Dr. Corrie A. Naasz, MD |
|
|
Dr. David Chen, MD |
|
|
Dr. Joel Peter M. Tan, MD |
|
|
Dr. Berhane S. Asfaw, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dennis L. Barnett II, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wilbert R. Jones, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ripudaman Singh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Diane E. Levitan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James Floyd, MD |
|
|
Dr. Yasser Said, MD |